Neumora Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Neumora Therapeutics, Inc.
CIK #0001885522
EDGAR Form CIK 2011 - 2025
10-K [0001885522]
10-Q [0001885522]
3 [0001885522]
4 [0001885522]
8-K [0001885522]
D [0001885522]
SC 13D [0001885522]
SC 13G [0001885522]
Form 13D/13G Filer Form 13D/13G Subject Filed
K2 Healthventures Equity Trust LLC Neumora Therapeutics Inc [2025-08-11]
Softbank Group Corp Neumora Therapeutics Inc [2024-11-12]
FMR LLC Neumora Therapeutics Inc [2024-07-08]
FMR LLC Neumora Therapeutics Inc [2024-07-08]
Berns Paul L Neumora Therapeutics Inc [2024-02-14]
Softbank Group Corp Neumora Therapeutics Inc [2024-02-13]
Arch Venture Fund XII LP Neumora Therapeutics Inc [2023-10-02]
Amgen Inc Neumora Therapeutics Inc [2023-09-27]
Form 3/4/5 Subject 2011 - 2025
Neumora Therapeutics, Inc.
Burow Kristina
Milligan Michael Lee
Fust Matthew K
Duncan Jason
Pinto Joshua
Halawa Alaa
Ho Maykin
Berns Paul L
Piacquad David
Aurora Daljit Singh
Lenz Robert A.
Suh Carol Y.
Gosebruch Henry O
ARCH Venture Partners XII, LLC
Crandell Keith
Gillis Steven
ARCH Venture Fund XII, L.P.
Nelsen Robert
ARCH Venture Partners XII, L.P.
Bybee Clinton
ARCH Venture Fund X, L.P.
ARCH Venture Fund X Overage, L.P.
ARCH Venture Partners VII, LLC
ARCH Venture Partners X, LLC
ARCH Venture Fund VII, L.P.
ARCH Venture Fund VIII Overage, L.P.
ARCH Venture Partners VII, L.P.
ARCH Venture Partners X Overage, L.P.
ARCH Venture Partners VIII, LLC
ARCH Venture Partners X, L.P.
FMR LLC
Amgen Inc
Terms | Privacy | Guide
tony@aum13f.com